WELL Health Technologies Corp.
WELL.TO
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 21.08% | 39.66% | 37.12% | 47.41% | 36.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.08% | 39.66% | 37.12% | 47.41% | 36.42% |
| Cost of Revenue | 24.45% | 66.40% | 55.86% | 70.31% | 58.62% |
| Gross Profit | 17.14% | 16.07% | 19.01% | 25.64% | 17.23% |
| SG&A Expenses | 9.01% | 13.14% | 138.96% | 26.35% | 25.37% |
| Depreciation & Amortization | 11.24% | 21.01% | 14.40% | 18.56% | 7.97% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.91% | 40.49% | 175.73% | 48.36% | 40.18% |
| Operating Income | 86.83% | 27.46% | 146.57% | 32.10% | -12.37% |
| Income Before Tax | -1,529.16% | 89,046.56% | 286.72% | 87.43% | -222.12% |
| Income Tax Expenses | 4,384.95% | -201.81% | -192.96% | 121.78% | -100.81% |
| Earnings from Continuing Operations | -1,562.13% | 5,796.42% | 285.03% | 52.53% | -813.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -71.25% | -37.64% | -21.35% | -307.63% | 39.59% |
| Net Income | -949.77% | 2,001.81% | 205.42% | 34.52% | -67.43% |
| EBIT | 86.83% | 27.46% | 146.57% | 32.10% | -12.37% |
| EBITDA | 39.84% | 23.83% | 135.47% | 20.41% | -0.75% |
| EPS Basic | -905.46% | 1,923.08% | 200.66% | 28.40% | -59.73% |
| Normalized Basic EPS | 69.70% | 4.76% | -225.47% | -215.56% | 25.00% |
| EPS Diluted | -916.39% | 1,508.97% | 298.03% | 28.40% | -59.73% |
| Normalized Diluted EPS | 69.70% | 10.48% | -225.47% | -215.56% | 25.00% |
| Average Basic Shares Outstanding | 4.49% | 4.51% | 4.72% | 4.70% | 4.99% |
| Average Diluted Shares Outstanding | 4.49% | 11.56% | 4.72% | 4.70% | 4.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
